Tag Archives: AstraZeneca vaccine less effective against SA strain: study

LONDON: The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, researchers said on Sunday. The University of Witwatersrand, Johannesburg, which conducted the trial, said in a statement that the vaccine “provides minimal protection against mild-moderate Covid-19 infection” from the variant. But in a full paper due to be published on Monday, AstraZeneca said …

Read More »